In 2013, an influenza virus that had never before been detected began circulating among poultry in China. It caused several waves of human infection and in late 2016, the number of people to become sick from the H7N9 virus suddenly started to rise. As of late July 2017, nearly 1,600 people had tested positive for avian H7N9. Nearly 40 percent of those infected had died.
In early 2017, Yoshihiro Kawaoka, professor of pathobiological sciences at the University of Wisconsin–Madison School of Veterinary Medicine, received a sample of H7N9 virus isolated from a patient in China who had died of the flu. He and his research team subsequently began work to characterize and understand it. The first of those results are published today (Oct. 19, 2017) in Cell Host & Microbe.
For the first time, Kawaoka says, his team has identified an influenza virus strain that is both transmissible between ferrets (the best animal model proxy for human influenza infections) and lethal, both in the animal originally infected and in otherwise healthy ferrets in close contact with these infected animals.
“This is the first case of a highly pathogenic avian virus that transmits between ferrets and kills them,” Kawaoka says. “That’s not good for public health.”
Everyone in the influenza field knew it was only a matter of time before the virus became pathogenic in chickens, which is to say that it became capable of causing disease, but Kawaoka says it took several years. It was initially hard to detect because, unlike some other influenza viruses such as H5N2 — which is highly lethal in chickens and caused significant outbreaks on poultry farms across the U.S. and elsewhere in 2015 — H7N9 was not killing the chickens it infected.
Instead, it remained silent, passing unknown from chicken to chicken and, occasionally, infecting humans that came into contact with the birds.
Influenza viruses are well known for their propensity to adapt. With each new infection of a host, small changes take place within the genomes of influenza viruses. Sometimes these mutations occur in key regions and lead to significant alterations to the original virus, rendering it capable of infecting new hosts, making hosts sick, causing greater illness, and becoming resistant to the drugs typically used to treat them.
Kawaoka and his team observed this within the sample isolated from the deceased patient, who while alive had been treated with the common flu drug Tamiflu. Using a technique to read the genetic identity of the virus population that had infected the patient, Kawaoka’s team learned the virus had started to mutate: The sample contained a population of H7N9 virus that was sensitive to Tamiflu and a population that was resistant.
So the team created two viruses virtually identical to those isolated from the patient, one sensitive to Tamiflu and the other bearing the mutation that conferred resistance to the drug. Comparing this to a low-pathogenic version of the H7N9 virus that Kawaoka and others had previously studied, the research team assessed how well each virus grows in human respiratory cells, where most influenza viruses take up residence in the body. They found that each grew efficiently, though the resistant strain was less effective than the other two.
The team also found that each virus infects and causes illness, to varying degrees, in several animal models for influenza — mice, ferrets and macaques.
To test whether the virus was transmissible between mammals, the researchers set up experiments in which ferrets were housed alone in individual cages separated by a barrier that allowed respiratory droplets to pass from one cage to the next. In each pair, one ferret was deliberately infected with the virus while the other was placed into the cage healthy.
Each of the three virus types were transmitted from infected ferrets to the previously uninfected animals. Two of three ferrets infected with the nonresistant strain of H7N9 — the strain currently circulating in China — died, as did the animals to which they passed the virus.
“Without additional mutations, the virus transmitted and killed ferrets,” says Kawaoka, noting that further alterations to the virus may not be necessary to make it a potential public health threat, though human-to-human transmission has thus far remained limited.
“I don’t want to cause alarm,” Kawaoka says, but “it’s only a matter of time before the resistant virus acquires a mutation that allows it to grow well, (rendering it) more likely to be lethal at the same time it is resistant.”
However, Kawaoka and his team are currently unable to better understand what mutations may enable this transition, at least in the United States, where a moratorium on work that might cause a pathogen to take on a new function not currently known in nature has been in place for several years.
“We can’t do the experiments to find out why,” Kawaoka says. “We really need to understand why H7N9 is lethal and transmissible, and what is different in this one resistant H7N9. If we knew that, because there are multiple viruses circulating, we could narrow down efforts to those that are lethal and transmissible.”
“Results from (gain-of-function) studies would almost certainly help in understanding the pandemic potential of influenza viruses and produce public health benefits, such as the prioritization and development of pre-pandemic vaccines and antiviral drugs,” the authors write. Fundamental (gain-of-function) research on transmissibility, host-range restriction, drug resistance, immunogenicity, pathogenicity, and replicative ability would also benefit global public health.”
The H7N9 virus is likely to continue to mutate as it infects humans, resulting in adaptations that enhance the viruses’ pathogenicity or ability to pass from person to person, Kawaoka adds. In other words, nature is already performing its own gain-of-function experiments, with potentially serious consequences.
It has, however, become a bit easier recently to detect when poultry are infected with H7N9, thereby allowing people to limit their exposure. That’s because the virus has begun to kill birds in China, too. But unlike in the U.S., where farmers cull their flocks to limit the spread of infectious disease, China relies on vaccines. This worries Kawaoka, given how well the virus has been shown to grow.
For now, he says: “We should improve our surveillance.”
The Latest on: H7N9 influenza
- Our ‘killer’ cells’ role in life-long flu vaccine on February 18, 2019 at 3:19 pm
Working with Fudan University in China, the team studied the immune responses of patients to the first outbreak of the avian-derived H7N9 influenza virus (bird flu) in China in 2013. This outbreak was ... […]
- Smuggled poultry risk spread of diseases on February 18, 2019 at 12:47 am
Poultry and cattle smuggled into Vietnam can potentially trigger an outbreak of infectious diseases, such as H5N1 and H7N9 bird flu and African hog cholera, said Deputy Minister of Agriculture and ... […]
- Healthwise: Why outbreaks occur, and how to stop them on February 18, 2019 at 12:34 am
H1N1 jumped from pigs to humans, which explains its “swine flu” nomenclature, in Mexico in April 2009, and infected and killed thousands in five continents within a few months. The H7N9 virus was firs... […]
- Hyderabad: No H5N1 detected in humans in last 2 years on February 16, 2019 at 2:03 pm
In the last few years, public health officials have been monitoring two such varieties of bird flu viruses: H7N9 and H5N8. “The mutation depends on the environment, such as atmospheric temperature and ... […]
- Avian Flu Treatment Market Growth, Trends and Value Chain 2016-2026 by FMI on February 15, 2019 at 5:00 am
Avian influenza is usually rare in humans but sometimes it passes to human and other species due to close contact with the infected bird. The common virus which can infect humans are A(H5N1) and A(H7N... […]
- Fears of avian influenza may have subsided, but risk remains on February 14, 2019 at 7:04 pm
Though no human cases of H5N1 avian influenza infection have been reported since February 2017 and only three human cases of H7N9 were reported in 2018, experts warn against complacency. Influenza vir... […]
- How well can H7N9 and H5N8 genetically mix with a seasonal strain? on February 14, 2019 at 4:41 pm
Emory scientists have been probing the RNA packaging factors that limit reassortment between avian H7N9/H5N8 strains and a well-known strain (H3N2) that has been dominating the last few human flu seas... […]
- Controversial flu studies can resume, U.S. panel says on February 14, 2019 at 11:12 am
But Fouchier says it suggested his team clarify how it will monitor workers for exposure and justify the flu strains it wants to work with, which include another bird virus, H7N9. HHS “is committed to ... […]
- China makes keeping tabs on bird flu difficult on February 14, 2019 at 7:21 am
If the last sample of a virus you have is from more than a few years ago, that’s really outdated. Especially with H7N9, a bird flu strain that started in 2013 as a low pathogenic virus but has recentl... […]
- Avian influenza outbreak detected near Lderitz on February 14, 2019 at 6:24 am
Shilongo said although Avian Influenza (H5N8) sub-type is not known to infect humans, others strains like the H5N1, H7N9 may be transmitted to humans. 'Humans can be infected with the virus via the ey... […]
via Google News and Bing News